The effect of topical steroid to prevent 5FU+ cisplatin induced phlebitis: a randomized, double-blind, placebo control, parallel group study.
Not Applicable
- Conditions
- Phlebitis from 5FU+ cisplatin therapy
- Registration Number
- JPRN-UMIN000017262
- Lead Sponsor
- Kyoto university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Difficult to accept the researcher by mental disorder, cognitive impairment or physical disability (2)using topical steroid on upper arm(e.g.dermatitis treatments) (3)Inappropriate for this study in physician judgement
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ength of the pigmentation of the first day of the second cycle of chemotherapy
- Secondary Outcome Measures
Name Time Method ength of the induration Occurrence of the phlebitis The number of days of developing phlebitis